NCT06210516Completed
Respiratory Muscle Training in Patients With Subacute Ischemic Stroke
Effect of Respiratory Muscle Training on Diaphragm Function and Activity Performance in Subacute Ischemic Stroke Patients: A Single-blind Randomised-controlled Trial
Source: ClinicalTrials.gov · Last updated 21 Oct 2024
Brief summary (registry, in English)
Stroke, which can occur due to many different reasons and is one of the most common neurological conditions, is one of the leading causes of disability worldwide. The most common disorders that occur after stroke are motor disorders. In addition, these patients may be accompanied by respiratory problems such as changes in breathing patterns and decreased ventilation function. Respiratory problems are an important risk factor for the development of long-term mortality for both cardiovascular diseases and stroke. With all these changes, there is a serious decrease in the activity performance of the patients. While stroke rehabilitation focuses on motor function losses, problems in pulmonary functions do not receive the necessary attention. Evaluating and treating patients from every aspect in stroke rehabilitation will further increase the effectiveness of the treatments applied. Ultrasonography (USG), which has been used in the field of healthcare for more than 40 years, works with a mechanism based on the principle of sound waves traveling and reflecting at different speeds in tissues of different densities. USG is a very useful and effective imaging method used by modern medicine as a part of examination and patient care, based on its advantages such as sound waves being harmless to living beings because they are non-ionizing, the image being real-time and being viewable at the time of the procedure, being a non-invasive method, and being inexpensive. This study will be included in the literature as an original study in terms of examining both the development of the patients and the effectiveness of the treatment in many aspects, with many parameters obtained by ultrasonography in subacute stroke patients who will receive respiratory muscle training.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 26 (actual)
- First submitted
- 4 Jan 2024
- Start date
- 20 Apr 2024
- Primary completion date
- 17 Sept 2024
- Lead sponsor
- Saglik Bilimleri Universitesi
- Diseases
- Stroke
- NCT number
- NCT06210516
What you commit to
- Study type: Interventional
- Participants enrolled: 26
- From 20 Apr 2024 to the primary completion date, 17 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having a psychiatric disease,
- Having any breathing problems before the stroke,
- Not having any orthopedic, neurological or cardiopulmonary disease that would constitute a contraindication for the protocols to be applied,
Other
- Hemispatial neglect,
- Being diagnosed with sarcopenia
Who the study is looking for
- Having had a stroke for the first time,
- Being 18 years or older,
- Having an ischemic type stroke,
- At least 1 month has passed since the stroke,
- Modified Rankin Score ≥ 3,
- Ability to communicate,
- Agreeing to participate in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Saglik Bilimleri University Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
Related publications
- Effect Of Inspiratory Muscle Traınıng on Diaphragm Functıon and Activıty Performance in Subacute Ischemıc Stroke Patıents: A Sıngle-Blind Randomized-Controlled Trial.Neurorehabil Neural Repair · 2026 · PMID 41589338
This page is information, not medical advice. Discuss any trial with your doctor.